Scientists at the University of Virginia have unveiled an experimental strategy to combat glioblastoma, one of the deadliest and most treatment-resistant forms of brain cancer. The approach combines focused ultrasound, microscopic nanoparticles, and genetic molecules known as microRNAs to simultaneously target multiple genes that drive tumor growth. By using sound waves to help deliver the therapy across the blood-brain barrier, the technique aims to overcome a major obstacle that has long limited effective treatment of brain tumors. The research represents an early but potentially significant advance in the fight against a cancer with few viable options.
Glioblastoma patients typically face a grim prognosis, with conventional treatments such as surgery, radiation, and chemotherapy offering limited survival benefits. The Virginia team's method seeks to disrupt the cancer at a genetic level, attacking several disease pathways at once rather than a single target, which may reduce the tumor's ability to develop resistance. While the findings remain experimental and require further testing before clinical application, researchers say the combined strategy could open new avenues for treating other hard-to-reach cancers as well. Independent experts caution that more studies are needed to confirm safety and efficacy in humans.
Independent reporting synthesized from primary wires and global correspondents.